J L Montero
Overview
Explore the profile of J L Montero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez E, Montero J, Molina E, Garcia-Buey L, Casado M, Fuentes J, et al.
Aliment Pharmacol Ther
. 2024 May;
59(12):1604-1615.
PMID: 38690746
Background: Suboptimal response to ursodeoxycholic acid occurs in 40% of primary biliary cholangitis (PBC) patients, affecting survival. Achieving a deep response (normalisation of alkaline phosphatase [ALP] and bilirubin ≤0.6 upper...
2.
Alonso S, Riveiro-Barciela M, Fernandez I, Rincon D, Real Y, Llerena S, et al.
J Viral Hepat
. 2016 Dec;
24(4):304-311.
PMID: 27935168
Patients with HCV genotype 3 (GT3) infection and cirrhosis are currently the most difficult to cure. We report our experience with sofosbuvir+daclatasvir (SOF+DCV) or sofosbuvir/ledipasvir (SOF/LDV), with or without ribavirin...
3.
Zurera L, Espejo J, Lombardo S, Marchal T, Munoz M, Canis M, et al.
Radiologia
. 2014 Dec;
57(5):419-27.
PMID: 25535030
Objective: To determine the degree of tumor necrosis in surgical specimens of hepatocellular carcinomas treated with microspheres preloaded with doxorubicin and to analyze the relationship between the degree of necrosis...
4.
Rodriguez-Ariza A, Monrobel A, Martinez-Galisteo E, Padilla C, Barcena J, Fraga E, et al.
Rev Esp Enferm Dig
. 2008 Apr;
100(3):129-38.
PMID: 18416637
Objectives: the postoperative evolution of patients submitted to orthotopic liver transplant (OLT) is frequently associated with the appearance of different types of complications such as renal failure, graft rejection, infections,...
5.
Montero J, Pozo J, Barrera P, Fraga E, Costan G, Dominguez J, et al.
Transplant Proc
. 2006 Nov;
38(8):2511-3.
PMID: 17097984
Unlabelled: Pruritus is a common complication of cholestatic liver diseases or liver graft dysfunction. Current medical therapies lack efficacy. The molecular adsorbent recirculating system (MARS) represents an interesting therapeutic option....
6.
Bernal E, Montero J, Delgado M, Fraga E, Costan G, Barrera P, et al.
Transplant Proc
. 2006 Nov;
38(8):2495-8.
PMID: 17097979
Unlabelled: Orthotopic liver transplantation (OLT) is the best treatment for nonresectable hepatocellular carcinoma (HCC), but tumor recurrence reduces long-term and medium-term survival. The effectiveness of adjuvant chemotherapy to prevent tumor...
7.
de la Mata M, Barrera P, Fraga E, Montero J, de la Torre J, Lopez-Cillero P, et al.
Gastroenterol Hepatol
. 2004 Oct;
27(7):425-8.
PMID: 15461943
No abstract available.
8.
de la Mata M, Barrera P, Montero J, Fraga E, Briceno J, Pozo J, et al.
Gastroenterol Hepatol
. 2004 Jun;
27 Suppl 1:52-6.
PMID: 15195535
No abstract available.
9.
Quintero A, Pedraza C, Siendones E, Kamal ElSaid A, Colell A, Garcia-Ruiz C, et al.
Free Radic Res
. 2002 Jun;
36(3):345-55.
PMID: 12071354
D-galactosamine (D-GalN) toxicity is a useful experimental model of liver failure in human. It has been previously observed that PGE1 treatment reduced necrosis and apoptosis induced by D-GalN in rats....
10.
de la Mata M, Montero J, Fraga E, Delgado M, Costan G, Padillo J, et al.
Gastroenterol Hepatol
. 2002 Apr;
23 Suppl 1:39-42.
PMID: 11968341
No abstract available.